Approximately thirty million American women will gain from the new health reform law over the next ten years, according to a new report from The Commonwealth Fund, a private foundation based in New York…
Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
31
Jul |
Thirty Million Women Will Gain From Health Reform Law, Including About 15 Million UninsuredCategory: Women's Health / Gynecology | Leave a Comment |
Approximately thirty million American women will gain from the new health reform law over the next ten years, according to a new report from The Commonwealth Fund, a private foundation based in New York…
|
31
Jul |
Hotspur Technologies Receives FDA 510(k) Clearance For First Three Product Lines Based On The Company’s Unique TechnologyCategory: Vascular | Leave a Comment |
Hotspur Technologies, Inc. announced that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur’s unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients…
|
31
Jul |
Fluorescent Biosensor Created To Aid In Drug DevelopmentCategory: Medical Devices / Diagnostics | Leave a Comment |
Researchers at Carnegie Mellon University have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs)…
|
30
Jul |
Automated Laboratory Solution Is Catalyst For Lean ChangeCategory: Medical Devices / Diagnostics | Leave a Comment |
A review of specimen reception and preliminary sample handling using ‘Lean’ principles has led to improvements in the processing of a daily workload of 11,000 samples at the Leicester Royal Infirmary (LRI) Pathology Department…
|
30
Jul |
Hospitals Accomodate Obese Patients By Purchasing New, Larger EquipmentCategory: Obesity / Weight Loss / Fitness | Leave a Comment |
Hospitals are accommodating the increasing number of obese patients by buying larger medical equipment, The Milwaukee Journal Sentinel reports. The new purchases are “eating into capital budgets and driving growth in the plus-sized medical equipment market. …
|
30
Jul |
AdvanDx Receives FDA 510(k) Clearance For 90 Minutes Protocol For Yeast Traffic Light® PNA FISH®Category: Blood / Hematology | Leave a Comment |
AdvanDx announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light® PNA FISH® test. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes…
|
30
Jul |
Boston Scientific Announces FDA Approval Of New Leads For The Precision Plus™ Spinal Cord Stimulator SystemCategory: Back Pain | Leave a Comment |
Boston Scientific Corporation (NYSE: BSX) announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world’s first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs…
|
29
Jul |
NRC, UOttawa Scientists First To Watch A Chemical Bond Break Using Molecule’s ElectronsCategory: Medical Devices / Diagnostics | Leave a Comment |
Scientists at the National Research Council of Canada (NRC) and the University of Ottawa (uOttawa) enjoyed a bird’s eye view of a chemical bond as it breaks. The making and breaking of chemical bonds underlie the biochemical processes of life itself…
|
29
Jul |
Ortho Kinematics Launches Multi-Site Clinical Study Of KineGraph VMA™Category: Medical Devices / Diagnostics | Leave a Comment |
Ortho Kinematics, a privately held spine diagnostics company focused on revolutionizing spine motion analysis, announced today that it has begun a multi-site clinical study of the KineGraph VMA™, and that the initial 23 patients have been enrolled. The study will help determine which types of patients are best evaluated with KineGraph VMA testing…
|
29
Jul |
Pioneer In ‘Ultraslow-Motion’ Imaging Receives American Chemical Society’s Highest HonorCategory: Biology / Biochemistry | Leave a Comment |
Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, has been named winner of the 2011 Priestley Medal by the American Chemical Society (ACS)…